Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+ -related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy

Bone Marrow Transplantation

Volumn 46, Issue 5, 2011, Pages 759-761

  El Mallawany, N K ^a   Geller, L ^b   Bollard, C M ^c   Wistinghausen, B ^b   Mussai, F ^d   Wayne, A S ^d   Alobeid, B ^a   Cairo, M S ^a,e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; LACTATE DEHYDROGENASE; LIVER ENZYME; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; THIOTEPA; VINCRISTINE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHILD; CYTOTOXIC T LYMPHOCYTE; DONOR LYMPHOCYTE INFUSION; DRUG DOSE REDUCTION; DRUG MEGADOSE; ECZEMA; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROA VACCINIFORME; HYDROA VACCINIFORME LIKE T CELL LYMPHOMA; LETTER; LIVING DONOR; LYMPHOCYTIC INFILTRATION; MALE; MULTIPLE CYCLE TREATMENT; PAPULOVESICULAR RASH; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; RASH; RECURRENT CANCER; RECURRENT DISEASE; SKIN BIOPSY; SYMPTOM; T CELL LYMPHOMA;

CHILD; EPSTEIN-BARR VIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; HYDROA VACCINIFORME; IMMUNOTHERAPY; LYMPHOMA, T-CELL; MALE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 79955895064     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.176     Document Type: Letter

References (7)

1. Lim MS, De Leval L, Quintanilla-Martinez L. Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms. J Hematopathol 2009; 2: 65-73
2. Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol 2009; 20: 1472-1482
3. Barrionuevo C, Anderson VM, Zevallos-Giampietri E, Zaharia M, Misad O, Bravo F et al. Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. Appl Immunohistochem Mol Morphol 2002; 10: 7-14 (Pubitemid 34178270)
4. Sato E, Ohga S, Kuroda H, Yoshiba F, Nishimura M, Nagasawa M et al. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan. Am J Hematol 2008; 83: 721-727
5. Bollard CM, Gottschalk S, Leen AM, Weiss H, Straathof KC, Carrum G et al. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood 2007; 110: 2838-2845 (Pubitemid 350006936)
6. Corradini P, Dodero A, Zallio F, Caracciolo D, Casini M, Bregni M et al. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reducedintensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 2004; 22: 2172-2176 (Pubitemid 41095152)
7. Focosi D, Caracciolo F, Galimberti S, Papineschi F, Petrini M. False positive PET scanning caused by inactivated influenza virus vaccination during complete remission from anaplastic T-cell lymphoma. Ann Hematol 2008; 87: 343-344